Bluejay Diagnostics, Inc. (BJDX) vs Telesis Bio Inc. (TBIO)
Bluejay Diagnostics, Inc. and Telesis Bio Inc. are both Medical Devices companies. Telesis Bio Inc. is the larger, with a market value of $5.3M against $4.3M — 1.2× the size. Telesis Bio Inc. has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 1.2×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −287.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Bluejay Diagnostics, Inc. leads on 6 and Telesis Bio Inc. on 6.
Valuation
Profitability
| Metric | BJDX | TBIO | Medical Devices median |
|---|---|---|---|
| Gross margin | 0.00% | 45.62% | 56.01% |
| Operating margin | 0.00% | (265.73%) | (15.03%) |
| Net margin | 0.00% | (287.90%) | (20.40%) |
| Free cash flow margin | 0.00% | (143.25%) | (7.24%) |
| Return on equity | (98.89%) | 1,013.88% | (15.32%) |
| Return on assets | (81.07%) | (73.87%) | (19.72%) |
| Return on invested capital | 0.00% | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack